Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada 2026 Inflammatory Bowel Disease (IBD) Fellowship- United StatesRelease Date:Fellowship Inflammation & Immunology USA Improving quality of care for patients with Relapsed/Refractory Multiple Myeloma (RRMM) treated with BCMA BsAbsRelease Date:Quality Improvement Oncology Italy 2026 Headache Medicine Fellowship - USRelease Date:Fellowship Internal Medicine USA Research on Long-Acting Growth HormoneRelease Date:Research Rare Disease All Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local LevelRelease Date:Quality Improvement Inflammation & Immunology China Real-World Evidence of SUL-DUR on Special Populations with CRAB InfectionRelease Date:Research Inflammation & Immunology China Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator TherapyRelease Date:Education Inflammation & Immunology USA Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold InfectionsRelease Date:Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom Title Grant Type Focus Area Country Application Due Date Promoting Pain Treatment in Osteoarthritis CareRelease Date:Education Internal Medicine Japan Appropriate Immunization among Patients with Immune-Mediated Inflammatory Diseases (IMIDs)Release Date:Quality Improvement Inflammation & Immunology All Developing Clinical Research and Publication Skills（Asia, AfME, Latin America and China）Release Date:Partner: British Medical Journal (BMJ)Education Internal Medicine All A Phased Approach to Understanding and Addressing Healthcare Disparities for People of ColorRelease Date:Partner: Conquer Cancer, The ASCO FoundationResearch Oncology USA PCF-Pfizer-Myovant Relugolix Challenge AwardsRelease Date:Partner: The Prostate Cancer Foundation and Myovant Sciences GmbHResearch Oncology USA BRAF-mutation Biomarker Testing in Colorectal Cancer and MelanomaRelease Date:Quality Improvement Oncology Canada Pfizer Innovation Challenge: Patient Preference Database BlueprintRelease Date:Research Support for the Professions All Management of Uterine Fibroids and EndometriosisEducation Internal Medicine USA COVID-19 Impact and SARS-CoV-2 Viral LifecycleRelease Date:Education Hospital USA Addressing Knowledge Gaps on Biosimilar Use in Inflammatory ConditionsRelease Date:Education Inflammation & Immunology USA Dermatology Research Fellowship in Skin of ColorFellowship Inflammation & Immunology USA NSCLC Therapy Management for Optimal Outcomes(Asia, Africa, Middle East, Latin America)Release Date:Quality Improvement Oncology All